Glyxambi 10 mg/1 (Empagliflozin and Linagliptin TABLET, FILM COATED) 10 mg/1

Glyxambi 10 mg/1 combines empagliflozin and linagliptin for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Strength

10 mg/1

Pack Size

30 TABLET, FILM COATED in 1 BOTTLE (0597-0182-30)

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Glyxambi 10 mg/1 is used to help manage type 2 diabetes by improving blood sugar levels. It combines two active ingredients, empagliflozin and linagliptin, to support glycemic control. This medication is typically prescribed alongside diet and exercise for comprehensive diabetes management. People often ask, 'What is Glyxambi used for?'—it's designed to assist in maintaining stable blood sugar levels.

Side Effects

Common effects of Glyxambi 10 mg/1 may include urinary tract infections, hypoglycemia, and upper respiratory tract infections. Some users might experience dizziness or headaches. These effects can vary and are not exhaustive; individual responses may differ.

Precautions & Warnings

Glyxambi 10 mg/1 should be handled with care, especially for those with kidney issues or a history of pancreatitis. It's important to follow healthcare provider instructions and monitor blood sugar levels regularly. Always store the medication as directed and keep it out of reach of children.

Avoid Interactions

Glyxambi 10 mg/1 may interact with other medications, including insulin, sulfonylureas, and certain antibiotics. Alcohol consumption should be moderated, as it can affect blood sugar levels. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Glyxambi 10 mg/1 is used to manage type 2 diabetes by helping to control blood sugar levels.

Glyxambi 10 mg/1 is taken orally, typically once daily, as prescribed by a healthcare provider.

Common side effects may include urinary tract infections, hypoglycemia, and upper respiratory tract infections.

Glyxambi 10 mg/1 may interact with other diabetes medications, so it's important to consult a healthcare provider before combining treatments.

Glyxambi 10 mg/1 should be used with caution in individuals with kidney issues; consult a healthcare provider for personalized advice.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.